As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the waste management industry, including Republic Services (NYSE:RSG) and its peers.
Looking back on vertical software stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.
Let’s dig into the relative performance of Upland (NASDAQ:UPLD) and its peers as we unravel the now-completed Q4 sales and marketing software earnings season.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Unity (NYSE:U) and the best and worst performers in the design software industry.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at consumer subscription stocks, starting with Chegg (NYSE:CHGG).
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IBM (NYSE:IBM) and the rest of the it services & consulting stocks fared in Q4.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q4, starting with Edgewell Personal Care (NYSE:EPC).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at healthcare distribution & related services stocks, starting with Patterson Companies (NASDAQ:PDCO).
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the defense contractors stocks, including Lockheed Martin (NYSE:LMT) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Commercial Vehicle Group (NASDAQ:CVGI) and the best and worst performers in the heavy transportation equipment industry.
Looking back on immuno-oncology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Regeneron (NASDAQ:REGN) and its peers.
